Inglese

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

1 moduli  
Study administration
Descrizione

Study administration

Center
Descrizione

Center

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Date of Visit
Descrizione

Date of Visit

Tipo di dati

date

Alias
UMLS CUI [1]
C1320303
Subject Number
Descrizione

Subject Identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
MEDICATION
Descrizione

MEDICATION

Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
Descrizione

pharmaceutical preparations

Tipo di dati

integer

Alias
UMLS CUI [1]
C0013227
MEDICATION
Descrizione

MEDICATION

undefined item
Descrizione

undefined item

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
MEDICATION
Item
Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
integer
C0013227 (UMLS CUI [1])
pharmaceutical preparations
Code List
Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
CL Item
No (1)
CL Item
Yes, please complete the following table. (2)
Item Group
MEDICATION
undefined item
Item
text
Ritorna all'inizio della pagina